Data / Form D filings / TRILOGIC PHARMA LLC
TRILOGIC PHARMA LLC: Form D filings
TRILOGIC PHARMA LLC, a pharmaceuticals company in Montgomery, AL, filed 6 Form D notices with the SEC between 2009 and 2012. The latest, on August 1, 2012, reports $222,866 sold of a $323,750 offering to 11 investors.
Find out what TRILOGIC PHARMA LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5331 PERIMETER PARKWAY COURT, Montgomery, AL, 36116
- Phone
- (334) 315-8981
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1427303
The full lists. Form D filings in Alabama: 291 rows, $14.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2012 | New notice | $323,750 | $222,866 | $100,884 | 11 | Jun 12, 2012 | sec.gov |
| Aug 15, 2011 | New notice | $450,000 | $415,000 | $35,000 | 15 | Feb 22, 2011 | sec.gov |
| Apr 2, 2010 | Amendment | $1,000,000 | $735,000 | $265,000 | 17 | Dec 16, 2009 | sec.gov |
| Jan 8, 2010 | Amendment | $1,000,000 | $425,000 | $575,000 | 17 | Dec 16, 2009 | sec.gov |
| Jan 8, 2010 | New notice | $1,000,000 | $425,000 | $575,000 | 17 | Jan 16, 2009 | sec.gov |
| May 20, 2009 | New notice | $1,600,000 | $1,600,000 | $0 | 51 | Sep 6, 2007 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| HERMANT H. ALUR | Executive Officer, Director | |
| WILLIAM VAN HOOSER | Director | |
| WILLIAM C. MAICHLE | Director | |
| ERNEST C. HORNSBY | Director | |
| JAMES A. H. HARWICK | Executive Officer, Director | |
| WESLEY R. HEATON | Executive Officer, Director | |
| RANDY B. STANLEY | Director | |
| ALEXANDER H. C. HARWICK | Director | |
| DANIEL P. WILBANKS | Director |
Every Form D from the week of Jul 30, 2012 · All recent filings in Alabama · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TRILOGIC PHARMA LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.